Home

Biomarkers

Read time: 3 min

Congress highlights

Searching for (possible) schizophrenia subtypes and markers

At the EPA 2017 symposium on subtypes of schizophrenia, we were presented with the novel hypothesis...

Parkinson's Disease

Read time: 4 min

Congress highlights

Boom or bust in biomarkers: is the heterogeneity of PD slowing our search?

We should combine forces, harmonise protocols for collecting material, and accept the need to...

Parkinson's Disease

Read time: 4 min

Congress highlights

From bowels to brain: the prion hypothesis in Parkinson’s

The idea that Parkinson’s Disease begins with alpha-synuclein pathology in the gut which then...

Parkinson's Disease

Read time: 4 min

Congress highlights

Plea for personalised medicine in PD

Well-established therapies for Parkinson’s Disease focus on motor symptoms. In comparison,...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

The tip of the iceberg

At the EPA 2017 symposium on autism spectrum disorders, the latest approaches being employed to...

Depression, Schizophrenia

Read time: 1 min

Voice from the floor - inflammation in the future

Alzheimer's Disease

Read time: 3 min

Is preventing Alzheimer’s Disease a practical proposition?

A prospective cohort study is under way in high-risk subjects, with the aim of validating potential...

Read time: 6 min

Picking threads from the rich tapestry of 2016

A round-up from refugee mental health to cognitive training and the effects of a light-box on...

Alzheimer's Disease, Parkinson's Disease

Read time: 5 min

To sleep or not to sleep: links with neurodegenerative disease

Disrupted sleep is a major consequence of Alzheimer’s Disease, but could it also help cause...

Read time: 4 min

Congress highlights

What are the chances? - The search for biomarkers in bipolar disorders

Biomarkers that could help in earlier recognition of bipolar disorders (BD) or that could reveal...

Read time: 4 min

Congress highlights

Predictors of drug-related adverse events, and inflammatory mediators linked to depression

Threads from a clinical symposium on biomarkers may help identify people at risk of depression and...

Read time: 3 min

Congress highlights

New insights on inflammation and neuroimmune function in depression

Proinflammatory cytokines and their soluble receptors are increased in the plasma of patients with...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country